Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00377273 · ClinicalTrials.gov registry record · Phase 4
An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses
A Phase 4 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 4
- Development phase
- 250
- Enrollment target
NCT00377273 is a Phase 4 study that has completed, run by Sanofi. The registered enrollment target is 250 participants.
The verdict
NCT00377273, a Phase 4 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 250 participants
- Enrollment target
Study Summary
This study is being undertaken to: 1. assess the safety of fluorouracil cream for the treatment of actinic keratoses ("AKs") on other common skin surface areas (e.g., posterior scalp, ears, neck, lips, arms and hands); 2. collect additional post-treatment safety data on fluorouracil cream applied to the face (including anterior scalp, if applicable); 3. assess the incidence of recurrence of AKs on the face; and 4. assess the need for re-treatment with fluorouracil cream to the face.
Interventions
- DRUG fluorouracil cream 0.5%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2003-11 |
| Est. Completion | 2005-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00377273
The ClinicalTrials.gov registry entry for NCT00377273 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fluorouracil cream 0.5% is the first listed.
NCT00377273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00377273 about?
NCT00377273 is a clinical study titled "An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses". This study is being undertaken to: 1. assess the safety of fluorouracil cream for the treatment of actinic keratoses ("AKs") on other common skin surface areas (e.g., posterior scalp, ears, neck, lips, arms and hands); 2. collect additional post-treatment safety data on fluorouracil cream applied to...
What is the current status of trial NCT00377273?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 250 participants. The study started on 2003-11. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00377273?
The interventions under investigation include: fluorouracil cream 0.5% (DRUG).
Who is sponsoring clinical trial NCT00377273?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.